Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

2,852

datasets available to search

ShareScore release 0.7.1

Reset

Dataset results

2,852 results for “Hepatocellular carcinoma”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov36/100

Plasma Sphingolipid Metabolites and Radiotherapy Efficacy in Hepatocellular Carcinoma

ClinicalTrials.gov study NCT06864221. IPD Sharing: NO. Countries: 1. Publications: 11.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma

ClinicalTrials.gov study NCT01655693. IPD Sharing: Not stated. Countries: 11. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Loc

ClinicalTrials.gov study NCT03867084. IPD Sharing: YES. Countries: 31. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

PSMA PET for the Staging and Management of Hepatocellular Carcinoma

ClinicalTrials.gov study NCT07019844. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI

ClinicalTrials.gov study NCT04891874. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma

ClinicalTrials.gov study NCT01258608. IPD Sharing: YES. Countries: 7. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma

ClinicalTrials.gov study NCT03628651. IPD Sharing: YES. Countries: 7. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)

ClinicalTrials.gov study NCT02821754. IPD Sharing: YES. Countries: 1. Publications: 5.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Proton Beam Therapy for Treatment of Hepatocellular Carcinoma

ClinicalTrials.gov study NCT00614913. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-00

ClinicalTrials.gov study NCT03713593. IPD Sharing: YES. Countries: 21. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk Patients

ClinicalTrials.gov study NCT01446666. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

ClinicalTrials.gov study NCT00105443. IPD Sharing: Not stated. Countries: 23. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular Carcinoma

ClinicalTrials.gov study NCT01594125. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma

ClinicalTrials.gov study NCT01774344. IPD Sharing: UNDECIDED. Countries: 21. Publications: 4.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma

ClinicalTrials.gov study NCT02528643. IPD Sharing: NO. Countries: 9. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation

ClinicalTrials.gov study NCT04102098. IPD Sharing: YES. Countries: 26. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy

ClinicalTrials.gov study NCT01755767. IPD Sharing: NO. Countries: 16. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)

ClinicalTrials.gov study NCT01642186. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular Carcinoma

ClinicalTrials.gov study NCT01988493. IPD Sharing: Not stated. Countries: 3. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
zenodo32/100

DATA for manuscript entitled "Integrating Transcriptomes and Somatic Mutations to Identify RNA Methylation Regulators as a Prognostic Marker in Hepatocellular Carcinomas"

<p><strong>Raw data of TCGA dataset and&nbsp;7-meta data.</strong></p>

opencc-by-4.0Dec 2019View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record